Finance

Lists
BNGO:NASDAQ
BioNano Genomics Inc
1,44 US$
-1,71%
(-0,025) 1D
1,42 US$
-1,05% (-0,015)
After hours
Closed: 9 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Open
1,45 US$
High
1,50 US$
Low
1,43 US$
Mkt. cap
16,90 მლნ.
Avg. vol.
1,83 მლნ.
Volume
129,40 ათ.
52-wk high
2,23 US$
52-wk low
1,00 US$
EPS
-3,76 US$
Beta
1,66
Shares outstanding
11,78 მლნ.
No. of employees
96
Open
1,45 US$
High
1,50 US$
Low
1,43 US$
Mkt. cap
16,90 მლნ.
Avg. vol.
1,83 მლნ.
Volume
129,40 ათ.
52-wk high
2,23 US$
52-wk low
1,00 US$
EPS
-3,76 US$
Beta
1,66
Shares outstanding
11,78 მლნ.
No. of employees
96
News stories
From web sources and news partners
About BioNano Genomics Inc
CEOერიკ ჰოლმლინ
Employees96
Founded2003
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth care
Websitebionano.com
Analyst ratings
Based on 1 analyst giving stock ratings to BNGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BNGO in the last 3 months
Highest
Current 1,44 US$
4,00 US$ (+178,75%)
Average
4,00 US$ (+178,75%)
Lowest
4,00 US$ (+178,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 US$
+178,7%
09/10/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
6,00 US$
+318,1%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
7,37 მლნ.
7,95 მლნ.
6,69 მლნ.
8,17 მლნ.
Cost of goods sold
4,00 მლნ.
4,55 მლნ.
3,44 მლნ.
3,86 მლნ.
Cost of revenue
4,00 მლნ.
4,55 მლნ.
3,44 მლნ.
3,86 მლნ.
Research and development expenses
2,84 მლნ.
3,23 მლნ.
3,14 მლნ.
2,99 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 მლნ.
8,71 მლნ.
8,01 მლნ.
8,54 მლნ.
Operating expense
11,91 მლნ.
11,94 მლნ.
11,15 მლნ.
11,53 მლნ.
Total operating expenses
15,90 მლნ.
16,49 მლნ.
14,58 მლნ.
15,39 მლნ.
Operating income
-8,54 მლნ.
-8,54 მლნ.
-7,90 მლნ.
-7,22 მლნ.
Other non operating income
-150,00 ათ.
434,00 ათ.
-547,00 ათ.
-274,00 ათ.
EBT including unusual items
-8,49 მლნ.
-7,90 მლნ.
-8,29 მლნ.
-7,42 მლნ.
EBT excluding unusual items
-8,49 მლნ.
-7,90 მლნ.
-8,29 მლნ.
-7,42 მლნ.
Income tax expense
14,00 ათ.
35,00 ათ.
10,00 ათ.
7,00 ათ.
Effective tax rate
-0,16%
-0,44%
-0,12%
-0,09%
Other operating expenses
-
-
-
-
Net income
-8,50 მლნ.
-7,93 მლნ.
-8,30 მლნ.
-7,42 მლნ.
Net profit margin
-115,42%
-99,77%
-124,17%
-90,85%
Earnings per share
-1,59
-0,03
-0,75
-0,60
Interest and investment income
268,00 ათ.
276,00 ათ.
223,00 ათ.
146,00 ათ.
Interest expense
-69,00 ათ.
-72,00 ათ.
-72,00 ათ.
-70,00 ათ.
Net interest expenses
199,00 ათ.
204,00 ათ.
151,00 ათ.
76,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,11 მლნ.
-6,15 მლნ.
-5,54 მლნ.
-4,87 მლნ.
Gain or loss from assets sale
-
-
34,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები